Clinical Significance of Thrombin Blockade with Low Doses (2.5 mg) of Rivaroxaban in Ischemic Heart Disease Patients

• Autores principales: A. B. Sumarokov (Autor), L. I. Buryachkovskaya (Autor), Y. V. Docenko (Autor), M. S. Kurochkin (Autor), N. V. Lomakin (Autor)
• Formato: Libro
• Publicado: Столичная издательская компания, 2020-03-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Arterial thrombosis is a result of complex interaction between blood cells, soluble coagulation factors in plasma and vessel wall. Antiplatelet drugs do not always provide the necessary antithrombotic effect of sufficient strength, because their influence does not extend to all three factors involve...